Label: BACITRACIN ointment
- NDC Code(s): 45802-060-01, 45802-060-03, 45802-060-70
- Packager: Padagis Israel Pharmaceuticals Ltd
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated November 10, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (each gram contains)
- Purpose
- Uses
- Warnings
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
BACITRACIN
bacitracin ointmentProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:45802-060 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BACITRACIN (UNII: 58H6RWO52I) (BACITRACIN - UNII:58H6RWO52I) BACITRACIN 500 [USP'U] in 1 g Inactive Ingredients Ingredient Name Strength LIGHT MINERAL OIL (UNII: N6K5787QVP) PETROLATUM (UNII: 4T6H12BN9U) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:45802-060-70 144 in 1 CARTON 06/20/2011 1 0.9 g in 1 PACKET; Type 0: Not a Combination Product 2 NDC:45802-060-01 1 in 1 CARTON 09/01/2011 2 14 g in 1 TUBE; Type 0: Not a Combination Product 3 NDC:45802-060-03 1 in 1 CARTON 08/05/2011 3 28 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part333B 06/20/2011 Labeler - Padagis Israel Pharmaceuticals Ltd (600093611)